Anti-C1q antibodies in systemic lupus erythematosus
β Scribed by Orbai, A.-M.; Truedsson, L.; Sturfelt, G.; Nived, O.; Fang, H.; Alarcon, G. S.; Gordon, C.; Merrill, J.; Fortin, P. R.; Bruce, I. N.; Isenberg, D. A.; Wallace, D. J.; Ramsey-Goldman, R.; Bae, S.-C.; Hanly, J. G.; Sanchez-Guerrero, J.; Clarke, A. E.; Aranow, C. B.; Manzi, S.; Urowitz, M. B.; Gladman, D. D.; Kalunian, K. C.; Costner, M. I.; Werth, V. P.; Zoma, A.; Bernatsky, S.; Ruiz-Irastorza, G.; Khamashta, M. A.; Jacobsen, S.; Buyon, J. P.; Maddison, P.; Dooley, M. A.; Van Vollenhoven, R. F.; Ginzler, E.; Stoll, T.; Peschken, C.; Jorizzo, J. L.; Callen, J. P.; Lim, S. S.; Fessler, B. J.; Inanc, M.; Kamen, D. L.; Rahman, A.; Steinsson, K.; Franks, A. G.; Sigler, L.; Hameed, S.; Pham, N.; Brey, R.; Weisman, M. H.; McGwin, G.; Magder, L. S.; Petri, M.
- Book ID
- 126802719
- Publisher
- SAGE Publications
- Year
- 2014
- Tongue
- English
- Weight
- 137 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0961-2033
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract __Background__: AntiβC1q antibodies have been described in systemic lupus erythematosus (SLE) as well as in other connective tissue diseases. They have been considered as a marker for disease activity and presence of nephritis. __Objective__: The aim of this study was to determine the